HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
B T Gjertsen Selected Research
B T Gjertsen Research Topics
Disease
11
Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2017 - 01/2000
5
Neoplasms (Cancer)
01/2017 - 12/2007
3
BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
10/2017 - 07/2013
3
Acute Promyelocytic Leukemia
02/2013 - 01/2000
3
Necrosis
01/2002 - 02/2000
2
Leukemia
12/2004 - 08/2000
1
Philadelphia Chromosome
07/2013
1
Disease Progression
02/2013
1
Myeloid Leukemia (Leukemia, Myelocytic)
02/2013
1
Genetic Translocation (Chromosomal Translocation)
06/2008
1
Shock
05/2008
1
Li-Fraumeni Syndrome
04/2006
1
Autoimmune Diseases (Autoimmune Disease)
07/2004
1
Systemic Lupus Erythematosus (Libman-Sacks Disease)
07/2004
1
Carcinogenesis
12/2003
1
Autoimmune Hemolytic Anemia (Cold Agglutinin Disease)
10/2001
1
Lymphoproliferative Disorders (Lymphoproliferative Disorder)
10/2001
1
Residual Neoplasm
01/2000
Drug/Important Bio-Agent (IBA)
4
Proteins (Proteins, Gene)
FDA Link
03/2012 - 07/2004
3
Valproic Acid (Depakote)
FDA Link
Generic
05/2012 - 04/2006
2
Dasatinib (BMS 354825)
FDA Link
01/2016 - 07/2013
2
Theophylline (Theon)
FDA Link
Generic
02/2013 - 02/2011
2
Polymethyl Methacrylate (Sol)
IBA
10/2000 - 02/2000
1
nilotinib
FDA Link
10/2017
1
venetoclax
IBA
01/2017
1
navitoclax
IBA
01/2017
1
Interferons
IBA
01/2016
1
amsonic acid (DAS)
IBA
01/2016
1
BI 6727
IBA
01/2015
1
Biomarkers (Surrogate Marker)
IBA
01/2015
1
Phosphotransferases (Kinase)
IBA
01/2015
1
Imatinib Mesylate (Gleevec)
FDA Link
07/2013
1
Tyrosine Kinase Inhibitors
IBA
07/2013
1
Daunorubicin (Cerubidine)
FDA Link
Generic
02/2013
1
Dinoprostone (PGE2)
FDA Link
02/2013
1
Anthracyclines
IBA
02/2013
1
Cyclic AMP (AMP, Cyclic)
IBA
02/2013
1
Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)
IBA
08/2012
1
Histone Deacetylases (Histone Deacetylase)
IBA
05/2012
1
nutlin 3
IBA
05/2012
1
Protein Isoforms (Isoforms)
IBA
03/2012
1
Intercellular Signaling Peptides and Proteins (Growth Factors)
IBA
02/2011
1
Cytokines
IBA
02/2011
1
nuclear pore complex protein 98
IBA
06/2008
1
Erythropoietin
FDA Link
05/2008
1
Angiopoietin-1
IBA
02/2008
1
Nucleophosmin
IBA
02/2008
1
Angiopoietin-2
IBA
02/2008
1
Histone Deacetylase Inhibitors
IBA
12/2007
1
Aminophylline (Carine)
FDA Link
Generic
04/2006
1
Tretinoin (Retinoic Acid)
FDA Link
Generic
04/2006
1
Autoantibodies
IBA
07/2004
1
Anti-ribosomal P protein autoantibodies
IBA
07/2004
1
Caspase Inhibitors
IBA
12/2003
1
IgE Receptors (Fc epsilon RI)
IBA
05/2002
1
Immunoglobulin E (IgE)
IBA
05/2002
1
Annexin A5
IBA
01/2002
1
Adrenal Cortex Hormones (Corticosteroids)
IBA
10/2001
1
Monoclonal Antibodies
IBA
10/2001
1
Interferon-alpha (Interferon Alfa)
IBA
10/2001
1
Alkylating Agents
IBA
10/2001
1
Rituximab (Mabthera)
FDA Link
10/2001
1
purine
IBA
10/2001
1
Bovine Serum Albumin
IBA
12/2000
1
Serum-Free Culture Media
IBA
12/2000
1
Polymers
IBA
10/2000
1
Indicators and Reagents (Reagents)
IBA
02/2000
1
Cytarabine (Cytosar-U)
FDA Link
Generic
01/2000
Therapy/Procedure
10
Therapeutics
01/2015 - 01/2000
5
Drug Therapy (Chemotherapy)
02/2013 - 01/2000
2
Denture Bases
10/2000 - 02/2000
2
Stem Cell Transplantation
08/2000 - 01/2000
1
Ligation
05/2002
1
Autologous Transplantation
08/2000
1
Transplantation
01/2000